Investment and M&A transaction comps
CPG Investment & M&A Transaction Comps
Global CPG and consumer brand investments, capital raises and M&A transactions, including food, beverage, beauty, personal care, supplements and adjacent branded consumer categories.
213
Reviewed transactions
149
With price data
4.1x
Median EV or valuation / revenue
16.3x
Median EV or valuation / EBITDA
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 12 | 9 | 4.0x | 9.9x |
| 2025 | 14 | 14 | 3.3x | 12.7x |
| 2024 | 12 | 11 | 3.6x | 16.0x |
| 2023 | 20 | 18 | 4.0x | 20.9x |
| 2022 | 20 | 10 | 4.9x | 20.4x |
| 2021 | 25 | 20 | 4.7x | 15.2x |
| 2020 | 15 | 10 | 4.2x | 14.7x |
| 2019 | 8 | 7 | 4.3x | 17.4x |
Sortable transaction comps
CPG transaction table
Rows with reported value
19 / 25
Acquisition EV, USD
USD 23B
Investment EV, USD
USD 4.1B
Median EV / revenue
4.7x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 213 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Main Event Entertainment Control (100%) | 2022-04-06 | Dave & Buster’s Entertainment, Inc. | USD 835M Enterprise Value | 835 | 2.2x | 9.0x | United States | Confirmed 4 sources | ||
| Orgain Control | 2022-02-02 | Nestlé Health Science | Undisclosed | Undisclosed | 1.5x | 22.0x | United States | Confirmed 1 source | ||
| Ilia Beauty Control | 2022-02-01 | Courtin-Clarins family / Clarins | EUR 612M Enterprise Value | 689 | 7.0x | 20.0x | - | Estimated 2 sources | ||
| Tula Control | 2022-01-04 | P&G | Undisclosed Undisclosed | Undisclosed | 6.7x | - | United States | Estimated 1 source | ||
| Chantecaille Control | 2021-12-21 | Beiersdorf | EUR 609M Enterprise Value | 688 | 4.6x | 15.3x | - | Confirmed 1 source | ||
| Supergoop Control | 2021-12-20 | Blackstone | EUR 618M Enterprise Value | 697 | 5.8x | - | United States | Confirmed 1 source | ||
| Del Taco Restaurants, Inc. Control (100%) | 2021-12-06 | Jack in the Box Inc. | USD 575M Enterprise Value | 575 | 1.1x | 11.0x | United States | Confirmed 11 sources | ||
| E45 Control | 2021-12-01 | Karo Healthcare | Undisclosed | Undisclosed | 4.7x | - | - | Confirmed 1 source | ||
| TheraBreath Control | 2021-11-29 | Church & Dwight | USD 580M Consideration | 580 | 5.0x | 13.8x | United States | Estimated 2 sources | ||
| ALASTIN Skincare Control | 2021-11-29 | Galderma | Undisclosed Undisclosed | Undisclosed | - | 8.6x | United States | Estimated 1 source | ||
| 2021-11-15 | Restaurant Brands International Inc. | USD 1.0B Enterprise Value | 1,000 | - | 20.0x | United States | Confirmed 4 sources | |||
| Sol de Janeiro Control (83%) | 2021-11-15 | L'Occitane | USD 450M Estimated Enterprise Value | 450 | 7.5x | 20.7x | United States | Estimated 5 sources | ||
| Obagi Control | 2021-11-15 | Waldencast | EUR 756M Enterprise Value | 865 | 4.5x | 17.2x | - | Confirmed 1 source | ||
| Milk Makeup Control | 2021-11-15 | Waldencast Acquisition Corp. | EUR 337M Enterprise Value | 386 | 5.8x | - | US (NY) | Estimated 1 source | ||
| 2021-11-10 | The Hershey Company | USD 1.2B Enterprise Value | 1,200 | 4.4x | - | United States | Confirmed 3 sources | |||
| Vuori Capital Raise | 2021-10-13 | SoftBank Vision Fund 2 | USD 4.0B Enterprise Value | 4,000 | - | - | United States | Confirmed 3 sources | ||
| Flexion Therapeutics Control | 2021-10-11 | Pacira BioSciences | Undisclosed | Undisclosed | - | 11.0x | United States | Confirmed 1 source | ||
| Héra / HRA Pharma Control | 2021-09-08 | Perrigo | USD 2.1B | 2,100 | 4.5x | - | - | Estimated 3 sources | ||
| Uqora Control | 2021-07-08 | Pharmavite | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Paula's Choice Control | 2021-06-14 | Unilever | USD 2.0B | 2,000 | 6.7x | 18.0x | - | Estimated 1 source | ||
| Bentley Laboratories Control | 2021-05-11 | THG | USD 255M Enterprise Value | 255 | - | 17.0x | New Jersey, United States | Estimated 1 source | ||
| 2021-04-30 | Nestlé | USD 5.8B Consideration | 5,750 | 3.1x | 16.8x | - | Confirmed 1 source | |||
| Vegamour Minority | 2021-04-13 | General Atlantic | USD 80.0M Investment Amount | 80 | 3.0x | 15.0x | - | Confirmed 1 source | ||
| Go-To Skincare Control (50%) | 2021-03-01 | BWX | AUD 177M Enterprise Value | 137 | 4.8x | 14.9x | Australia | Estimated 3 sources | ||
| Birkenstock Group Control | 2021-02-26 | L Catterton and affiliates, including Financière Agache | EUR 4.0B Enterprise Value | 4,848 | 5.5x | 25.0x | Germany | Estimated 5 sources |
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.